{"id":"https://openalex.org/W7204589019","doi":"https://doi.org/10.6084/m9.figshare.33368152","title":"Supplemental Material for: Complete Response to Low-Dose Fam-Trastuzumab Deruxtecan in Recurrent Endometrial Cancer with Liver and Peritoneal Metastases: A Case Report","display_name":"Supplemental Material for: Complete Response to Low-Dose Fam-Trastuzumab Deruxtecan in Recurrent Endometrial Cancer with Liver and Peritoneal Metastases: A Case Report","publication_year":2026,"publication_date":"2026-08-28","ids":{"openalex":"https://openalex.org/W7204589019","doi":"https://doi.org/10.6084/m9.figshare.33368152"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.33368152","doi":"https://doi.org/10.6084/m9.figshare.33368152","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33368152","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},"parent_works":[],"lineage":["https://openalex.org/W7204589019"],"child_works_count":0,"type":"supplementary-materials","is_traditional":false,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.33368152","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5146365916","display_name":"figshare admin karger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162602","display_name":"Karger Publishers (Switzerland)","ror":"https://ror.org/0572q5a45","country_code":"CH","type":"company","lineage":["https://openalex.org/I2802626578","https://openalex.org/I40120149","https://openalex.org/I4210162602"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"figshare admin karger","raw_affiliation_strings":["Karger Publishers (Switzerland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karger Publishers (Switzerland)","institution_ids":["https://openalex.org/I4210162602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101456896","display_name":"Fangyu Wang","orcid":"https://orcid.org/0000-0002-1706-8314","observed_orcids":["https://orcid.org/0000-0002-1706-8314"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fang-Yu Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148538862","display_name":"Cheng-Han Wu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheng-Han Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033428085","display_name":"Sung-Chao Chu","orcid":"https://orcid.org/0000-0002-2737-0787","observed_orcids":["https://orcid.org/0000-0002-2737-0787"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sung-Chao Chu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083534050","display_name":"Chiu-Hsuan Cheng","orcid":"https://orcid.org/0000-0002-9996-0428","observed_orcids":["https://orcid.org/0000-0002-9996-0428"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chiu-Hsuan Cheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148472290","display_name":"Yen-Chang Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yen-Chang Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102524472","display_name":"Han-Kuang Hsieh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Han-Kuang Hsieh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032954587","display_name":"Tso\u2010Fu Wang","orcid":"https://orcid.org/0000-0002-2251-6900","observed_orcids":["https://orcid.org/0000-0002-2251-6900"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tso-Fu Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5981000065803528,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5981000065803528,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.3610999882221222,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.010700000450015068,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.7080000042915344},{"id":"https://openalex.org/keywords/her2-positive-cancer","display_name":"HER2-positive cancer","score":0.6420000195503235},{"id":"https://openalex.org/keywords/erbb2-amplification","display_name":"ERBB2 amplification","score":0.8560000061988831},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.7570000290870667},{"id":"https://openalex.org/keywords/peritoneal-metastases","display_name":"peritoneal carcinomatosis","score":1.0},{"id":"https://openalex.org/keywords/recurrent-endometrial-cancer","display_name":"recurrent endometrial cancer","score":0.7540000081062317},{"id":"https://openalex.org/keywords/dose-de-escalation","display_name":"dose de-escalation","score":0.8930000066757202},{"id":"https://openalex.org/keywords/frail-older-patients","display_name":"frail elderly patients","score":0.8040000200271606},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.5659999847412109},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5870000123977661},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8180000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9253000020980835},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7233999967575073},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6417999863624573},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5587000250816345},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.5429999828338623},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5285000205039978},{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.5110999941825867},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5051000118255615},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.48019999265670776},{"id":"https://openalex.org/C2779742232","wikidata":"https://www.wikidata.org/wiki/Q839508","display_name":"Endometrium","level":2,"score":0.4542999863624573},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4016000032424927},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.38989999890327454},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3869999945163727},{"id":"https://openalex.org/C190892606","wikidata":"https://www.wikidata.org/wiki/Q3512464","display_name":"Radiological weapon","level":2,"score":0.35100001096725464},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.35040000081062317},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.3192000091075897},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30959999561309814},{"id":"https://openalex.org/C2994372414","wikidata":"https://www.wikidata.org/wiki/Q5625186","display_name":"Gynecologic cancer","level":4,"score":0.28839999437332153},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2784000039100647},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.27799999713897705},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.27469998598098755},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.2741999924182892},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.27230000495910645},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.26649999618530273},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.2639999985694885}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.33368152","doi":"https://doi.org/10.6084/m9.figshare.33368152","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33368152","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.33368152.v1","doi":"https://doi.org/10.6084/m9.figshare.33368152.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33368152.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.33368152","doi":"https://doi.org/10.6084/m9.figshare.33368152","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33368152","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7220669010","https://openalex.org/W4417297563","https://openalex.org/W4283774464","https://openalex.org/W7155440560","https://openalex.org/W4417449141","https://openalex.org/W4415500826","https://openalex.org/W4405071805","https://openalex.org/W4411289903","https://openalex.org/W4408090602","https://openalex.org/W7148899445"],"abstract_inverted_index":{"Introduction:":[0],"While":[1],"fam-trastuzumab":[2],"deruxtecan":[3],"(T-DXd)":[4],"has":[5],"demonstrated":[6],"significant":[7],"efficacy":[8],"in":[9,18,31,138,157],"HER2-expressing":[10],"solid":[11],"tumors,":[12],"its":[13],"optimal":[14],"dosing":[15,152],"and":[16,51,57,71,113],"tolerability":[17],"elderly":[19],"or":[20,160],"frail":[21,42,140],"patients":[22],"remain":[23],"poorly":[24],"defined.":[25],"Evidence":[26],"supporting":[27],"upfront":[28],"dose":[29,81,99],"de-escalation":[30],"gynecologic":[32],"malignancies":[33],"is":[34],"limited.":[35],"Case":[36],"Presentation:":[37],"We":[38],"report":[39],"a":[40,78,103,119,132,139],"73-year-old":[41],"woman":[43],"with":[44,77,110,142],"recurrent,":[45],"metastatic":[46],"endometrial":[47,145],"carcinoma":[48],"featuring":[49],"hepatic":[50],"peritoneal":[52],"metastases,":[53],"HER2":[54],"immunohistochemistry":[55],"3+,":[56],"high-level":[58],"ERBB2":[59],"amplification.":[60],"Following":[61],"progression":[62],"on":[63],"multiple":[64],"platinum-taxane":[65],"regimens,":[66],"bevacizumab,":[67],"surgery,":[68],"hormonal":[69],"therapy,":[70],"radiotherapy,":[72],"the":[73,97,148],"patient":[74,141],"was":[75],"treated":[76],"fixed,":[79],"reduced":[80],"of":[82,96,150],"T-DXd":[83,137],"at":[84,125],"100":[85],"mg":[86],"every":[87],"2":[88],"weeks":[89],"(2.27":[90],"mg/kg":[91],"per":[92],"administration,":[93],"approximately":[94],"63%":[95],"standard":[98],"intensity).":[100],"She":[101],"achieved":[102],"complete":[104],"radiological":[105],"response":[106,134],"by":[107],"6":[108],"months,":[109],"clinical":[111],"improvement":[112],"no":[114],"remarkable":[115],"adverse":[116],"events,":[117],"sustaining":[118],"progression-free":[120],"survival":[121],"exceeding":[122],"16":[123],"months":[124],"last":[126],"follow-up.":[127],"Conclusion:":[128],"This":[129],"case":[130],"illustrates":[131],"favorable":[133],"to":[135],"dose-reduced":[136],"strongly":[143],"HER2-driven":[144],"cancer,":[146],"raising":[147],"possibility":[149],"individualized":[151],"strategies":[153],"that":[154],"warrant":[155],"evaluation":[156],"larger":[158],"prospective":[159],"retrospective":[161],"cohorts.":[162]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-08-29T00:00:00"}